Value202020212022202320242025TTMSelling/general/admin expenses52.82 M96.8 M177.98 M173.61 M215.31 M284.27 M284.27 MResearch & development96.95 M159.94 M240.81 M330.12 M339.41 M416.03 M416.03 MOperating income-93.94 M-186.31 M-324.2 M-496.2 M-536.25 M612.26 M-255.53 MNon-Operating Income, Total5.33 M331 K11.34 M27.63 M51.53 M48.42 M48.42 MInterest expense, net of interest capitalized15.96 M16.44 M19.41 M28.31 M37.7 M45.58 M—Non-Operating Income, excl. Interest Expenses-10.63 M-16.11 M-8.07 M-677 K13.83 M2.84 M8.18 MUnusual income/expense———————Pretax income99.19 M186.53 M360.48 M523.83 M587.78 M660.68 M660.68 MEquity in earnings———————Taxes000000—Non-controlling/minority interest———————After tax other income/expense———————Net income before discontinued operations127.3 M215.3 M389 M526.2 M589.5 M784.96 M784.98 MDiscontinued operations———————Net income127.3 M215.3 M389 M526.2 M589.5 M784.96 M784.98 MDilution adjustment———————Preferred dividends———————Diluted net income available to common stockholders127.3 M215.3 M389 M526.2 M589.5 M784.96 M784.98 MBasic earnings per share (Basic EPS)——-4.33-5.45-5.26-6.54-6.56Diluted earnings per share (Diluted EPS)——-4.33-5.45-5.26-6.54-6.54Average basic shares outstanding——89.83 K96.52 K111.98 K120.1 K476.9 KDiluted shares outstanding——89.83 K96.52 K111.98 K120.1 K476.9 KEBITDA———————EBIT———————Cost of revenue———————Other cost of goods sold———————Depreciation & amortization (cash flow)1.83 M2.28 M5.81 M11.89 M9.53 M10.13 M10.13 M
Cytokinetics Incorporated
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.